34.54
price up icon6.74%   2.18
after-market Handel nachbörslich: 34.54
loading
Schlusskurs vom Vortag:
$32.36
Offen:
$32.64
24-Stunden-Volumen:
2.48M
Relative Volume:
0.86
Marktkapitalisierung:
$5.24B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
16.61
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
+12.65%
1M Leistung:
-21.12%
6M Leistung:
-32.47%
1J Leistung:
-43.72%
1-Tages-Spanne:
Value
$32.57
$34.63
1-Wochen-Bereich:
Value
$30.00
$34.63
52-Wochen-Spanne:
Value
$30.00
$72.94

Bruker Corp Stock (BRKR) Company Profile

Name
Firmenname
Bruker Corp
Name
Telefon
978663-3660
Name
Adresse
40 MANNING RD, BILLERICA, MA
Name
Mitarbeiter
11,396
Name
Twitter
@bruker
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
BRKR's Discussions on Twitter

Vergleichen Sie BRKR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BRKR
Bruker Corp
34.54 4.91B 3.24B 304.90M 156.70M 2.08
Medical Devices icon
ABT
Abbott Laboratories
129.40 228.03B 43.11B 13.98B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
102.50 152.09B 18.49B 2.51B 3.23B 1.68
Medical Devices icon
SYK
Stryker Corp
378.95 143.98B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
92.91 117.98B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.68 45.17B 5.69B 4.14B 577.90M 6.96

Bruker Corp Stock (BRKR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-22 Herabstufung Citigroup Buy → Neutral
2024-12-19 Eingeleitet Guggenheim Buy
2024-12-10 Eingeleitet UBS Neutral
2024-12-05 Hochstufung Goldman Sell → Neutral
2024-10-15 Eingeleitet Barclays Overweight
2024-09-30 Herabstufung Wolfe Research Outperform → Peer Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-02-14 Hochstufung JP Morgan Neutral → Overweight
2023-12-19 Eingeleitet Wells Fargo Equal Weight
2023-12-13 Eingeleitet Wolfe Research Outperform
2022-10-21 Eingeleitet UBS Buy
2022-08-22 Hochstufung Citigroup Neutral → Buy
2021-10-15 Fortgesetzt Cowen Market Perform
2021-06-15 Hochstufung Cleveland Research Neutral → Buy
2021-02-05 Herabstufung Wells Fargo Overweight → Equal Weight
2020-12-02 Eingeleitet Goldman Sell
2020-11-16 Hochstufung Wolfe Research Underperform → Peer Perform
2020-05-01 Herabstufung Cleveland Research Buy → Neutral
2020-04-02 Herabstufung Wolfe Research Peer Perform → Underperform
2020-04-01 Herabstufung Needham Strong Buy → Hold
2020-03-26 Hochstufung Barclays Equal Weight → Overweight
2020-01-08 Eingeleitet Wells Fargo Overweight
2020-01-07 Eingeleitet Citigroup Buy
2019-11-15 Eingeleitet Stifel Hold
2019-09-26 Hochstufung BofA/Merrill Neutral → Buy
2019-07-15 Hochstufung Goldman Sell → Neutral
2019-06-24 Bestätigt Needham Strong Buy
2019-06-21 Bestätigt BofA/Merrill Neutral
2019-05-30 Eingeleitet Wolfe Research Peer Perform
2019-05-06 Bestätigt Needham Strong Buy
2019-05-03 Hochstufung SVB Leerink Mkt Perform → Outperform
2019-05-03 Hochstufung UBS Sell → Neutral
2019-04-12 Hochstufung Deutsche Bank Hold → Buy
2019-02-12 Bestätigt BTIG Research Buy
2019-01-03 Eingeleitet Needham Strong Buy
Alle ansehen

Bruker Corp Aktie (BRKR) Neueste Nachrichten

pulisher
04:09 AM

Is Bruker Corporation stock risky to hold nowJuly 2025 PostEarnings & Comprehensive Market Scan Insights - thegnnews.com

04:09 AM
pulisher
Aug 12, 2025

Bruker Corp To Go Ex-Dividend On September 23rd, 2025 With 0.05 USD Dividend Per Share - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Bruker Maintains Quarterly Dividend of $0.05 per Share, Payable Oct. 3 to Holders of Record as of Sept. 23 - MarketScreener

Aug 12, 2025
pulisher
Aug 12, 2025

Bruker to pay $0.05 quarterly dividend in October By Investing.com - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Bruker Announces Quarterly Dividend - Stock Titan

Aug 12, 2025
pulisher
Aug 11, 2025

Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract - Yahoo Finance

Aug 11, 2025
pulisher
Aug 10, 2025

Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors - The Globe and Mail

Aug 10, 2025
pulisher
Aug 10, 2025

Why Investors Shouldn't Be Surprised By Bruker Corporation's (NASDAQ:BRKR) 31% Share Price Plunge - simplywall.st

Aug 10, 2025
pulisher
Aug 07, 2025

Bruker Corporation (BRKR): A Bull Case Theory - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

` - Insider Monkey

Aug 07, 2025
pulisher
Aug 07, 2025

Bruker Corp. (BRKR) Faces Funding Challenges, But Long-Term Fundamentals Remain Intact. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Bruker Corp. (BRKR) Sheds 8.6% on Dismal Earnings, Outlook - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Investors Don't See Light At End Of Bruker Corporation's (NASDAQ:BRKR) Tunnel And Push Stock Down 26% - 富途牛牛

Aug 07, 2025
pulisher
Aug 07, 2025

Unlocking Bruker (BRKR) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Bruker Corporation shares rise 1.11% premarket after securing multi-year contracts for explosives and chemical trace detection solutions. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings Miss: Bruker Corporation Missed EPS By 38% And Analysts Are Revising Their Forecasts - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Bruker Bets On Science, But Debt And Margins Weigh Heavy - Finimize

Aug 07, 2025
pulisher
Aug 07, 2025

Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus

Aug 07, 2025
pulisher
Aug 06, 2025

Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Bruker Secures Contracts for Explosives, Chemical Trace Detection - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Bruker Corp secures multi-year contracts for trace detection - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

BRUKER CORP SEC 10-Q Report - TradingView

Aug 06, 2025
pulisher
Aug 05, 2025

Bruker's Strategic Cost-Saving Initiatives and Margin Expansion Justify Buy Rating Amid Market Challenges - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 ResultsBruker (NASDAQ:BRKR) - Benzinga

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker stock price target lowered to $40 by TD Cowen on weak demand - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $50 - 富途牛牛

Aug 05, 2025
pulisher
Aug 05, 2025

A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $38 to $60 - 富途牛牛

Aug 05, 2025
pulisher
Aug 05, 2025

Stifel lowers Bruker stock price target to $40 on weak academic spending - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - 富途牛牛

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker: Q2 Earnings Snapshot - Norwalk Hour

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... By GuruFocus - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic Cost Reductions - GuruFocus

Aug 05, 2025
pulisher
Aug 04, 2025

Barclays lowers Bruker stock price target to $43 from $46, maintains Overweight rating By Investing.com - Investing.com South Africa

Aug 04, 2025
pulisher
Aug 04, 2025

Barclays lowers Bruker stock price target to $43 from $46, maintains Overweight rating - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

Why Bruker (BRKR) Shares Are Trading Lower Today - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Shares Fall on 2Q Earnings Miss, Lowered FY Outlook - 富途牛牛

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Shares Fall Amid Lower Q2 Adjusted Earnings, Revenue; 2025 Adjusted EPS, Revenue Guidance Cut - MarketScreener

Aug 04, 2025
pulisher
Aug 04, 2025

Earnings call transcript: Bruker Q2 2025 misses forecasts, stock drops By Investing.com - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

Earnings call transcript: Bruker Q2 2025 misses forecasts, stock drops - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Q2 2025 Earnings Call Transcript - MarketBeat

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Corporation stock hits 52-week low at 34.0 USD By Investing.com - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Corporation stock hits 52-week low at 34.0 USD - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Misses Expectations And Lowers Its Outlook For The Year - Finimize

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker Corp. Sees Modest Q2 Profit with Revenue GrowthNews and Statistics - IndexBox

Aug 04, 2025
pulisher
Aug 04, 2025

Bruker (BRKR) Misses Q2 Earnings Estimates - Yahoo Finance

Aug 04, 2025

Finanzdaten der Bruker Corp-Aktie (BRKR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bruker Corp-Aktie (BRKR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
ORNELL JOHN A
Director
May 13 '25
Option Exercise
18.15
5,000
90,750
31,445
LINTON WILLIAM A
Director
Apr 22 '25
Option Exercise
24.00
10,000
240,000
58,723
Bures Thomas
Chief Accounting Officer
Mar 10 '25
Buy
47.40
500
23,698
3,472
LAUKIEN FRANK H
PRESIDENT & CEO
Feb 18 '25
Buy
50.92
20,000
1,018,330
38,459,563
PACKER RICHARD A
Director
Dec 02 '24
Option Exercise
19.12
10,000
191,200
84,254
PACKER RICHARD A
Director
Dec 02 '24
Sale
57.82
3,350
193,683
80,904
$308.68
price down icon 0.31%
medical_devices STE
$247.07
price up icon 1.36%
medical_devices PHG
$27.29
price up icon 1.11%
$79.96
price down icon 0.26%
$75.33
price up icon 1.24%
medical_devices EW
$77.68
price up icon 0.97%
Kapitalisierung:     |  Volumen (24h):